Submitted on June 29, 2005
Revised on January 18, 2006
Accepted on January 23, 2006
Stable isotope tagging of epitopes-a highly selective strategy for the identification of MHC class I-associated peptides induced upon viral infection
H. D. Meiring, E. C. Soethout, M C. M. Poelen, D. Mooibroek, R. Hoogerbrugge, H. Timmermans, C. J. Boog, A. J. R. Heck, A. P. J. M. de Jong, and C. A C. M. van Els
Vaccine Research, Netherlands Vaccine Institute, Bilthoven 3720 AL
Corresponding Author: Ernst.Soethout{at}nvi-vaccin.nl
Identification of peptides presented in MHC class I molecules after viral infection is of strategic importance for vaccine development. Until recently, mass spectrometric identification of virus-induced peptides was based on comparative analysis of peptide pools isolated from uninfected and virus-infected cells. Here, we report on a powerful strategy aiming at the rapid, unambiguous identification of naturally processed MHC class I-associated peptides, which are induced by viral infection. The methodology, Stable Isotope Tagging of Epitopes (SITE), is based on metabolic labeling of endogenously synthesized proteins during infection. This is accomplished by culturing virus-infected cells with stable isotope labeled amino acids that are expected to be anchor residues (i.e. residues of the peptide that have amino acid side chains that bind into pockets lining the peptide-binding groove of the MHC class I molecule) for the HLA allele of interest. Subsequently, these cells are mixed with an equal number of non-infected cells, which are cultured in normal medium. Finally, peptides are acid-eluted from immunoprecipitated MHC molecules and subjected to 2-dimensional nanoscale LC-MS analysis. Virus-induced peptides are identified through computer-assisted detection of characteristic, binomially distributed ratios of labeled and unlabeled molecules. Using this approach we identified novel measles virus and respiratory syncytial virus epitopes as well as infection-induced self-peptides in several cell types, showing that SITE is a unique and versatile method for unequivocal identification of disease-related MHC class I epitopes.